DWC202313, DWC202314 Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions
Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.40 enrolled1 locationNCT07260851
Recruiting
Phase 1
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.36 enrolled1 locationNCT07267221